Shalby Limited (NSE:SHALBY)
India · Delayed Price · Currency is INR 127.49
+1.97 (1.57%)
Nov 12, 2026, 3:30 PM IST
Shalby Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 12,040 | 11,414 | 10,870 | 9,337 | 8,049 | 6,989 |
Revenue Growth | 7.27% | 5.01% | 16.41% | 16.00% | 15.16% | 62.21% |
Gross Profit Gross Profit Growth | 2,503 | 2,473 | 2,398 | 2,505 | 2,040 | 1,717 |
Operating Income Operating Income Growth | 762.97 | 802.31 | 721.53 | 1,287 | 926.86 | 787.61 |
Net Income Net Income Growth | 392.05 | 373.88 | 62.22 | 840.77 | 677.01 | 541.25 |
Earnings Per Share EPS Growth | 3.88 | 3.48 | 0.58 | 7.77 | 6.27 | 5.01 |
EPS Growth | - | 500.71% | -92.55% | 23.92% | 25.12% | 27.66% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Healthcare Services Healthcare Services Growth | 10,612 | 10,101 | 9,798 | 8,554 | 7,140 | 6,682 |
Manufacturing & Trading of Implants Manufacturing & Trading of Implants Growth | 1,427 | 1,313 | 1,072 | 783.35 | 909.55 | 307.84 |
Total Total Growth | 12,040 | 11,414 | 10,870 | 9,337 | 8,049 | 6,989 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 695.99 | 916.97 | 1,365 | 1,556 | 1,615 | 2,021 |
Total Debt Total Debt Growth | 5,855 | 5,946 | 4,759 | 3,779 | 1,805 | 1,741 |
Net Cash (Debt) Net Cash Growth | -5,159 | -5,029 | -3,395 | -2,223 | -190.22 | 280.61 |
Net Cash Growth | - | - | - | - | - | -62.69% |
Net Cash Per Share Net Cash Per Share Growth | -50.99 | -46.78 | -31.58 | -20.54 | -1.76 | 2.60 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 262.37 | -0.12 | -43.42 | 195.96 | 677.75 | 189.17 |
Capital Expenditures CapEx Growth | -988.9 | -1,490 | -714.46 | -471.07 | -184.82 | -753.93 |
Free Cash Flow Free Cash Flow Growth | -726.53 | -1,491 | -757.88 | -275.11 | 492.93 | -564.76 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 20.79% | 21.67% | 22.06% | 26.83% | 25.35% | 24.56% |
Operating Margin | 6.34% | 7.03% | 6.64% | 13.78% | 11.52% | 11.27% |
Pretax Margin | 4.57% | 5.31% | 5.13% | 13.73% | 12.68% | 11.32% |
Profit Margin | 3.26% | 3.28% | 0.57% | 9.00% | 8.41% | 7.74% |
FCF Margin | -6.03% | -13.06% | -6.97% | -2.95% | 6.12% | -8.08% |
Fiscal Year | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.200 | 1.200 | 1.000 |
Dividend Per Share Growth | 0% | 20.00% | 0% |
Dividend Yield | 0.50% | 0.89% | 0.85% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 32.90 | 36.45 | 340.21 | 30.52 | 21.27 | 23.35 |
Forward PE | - | 16.21 | 19.96 | 27.55 | 15.32 | 21.87 |
P/FCF Ratio | - | - | - | - | 29.22 | - |
PS Ratio | 1.14 | 1.19 | 1.95 | 2.75 | 1.79 | 1.81 |